Full-Time

Principal Scientist/Fellow

Pharmacology & Toxicology

Posted on 5/16/2024

Telix Pharmaceuticals

Telix Pharmaceuticals

201-500 employees

Develops radiopharmaceuticals for cancer and rare diseases

Biotechnology

Senior, Expert

Canada

Required Skills
Communications
Requirements
  • PhD or equivalent degree in Pharmacology, Toxicology, or a related scientific field
  • 7+ years of experience for Principal Scientist and 10+ years of experience for Fellow in pharmacology and toxicology
  • Strong knowledge of regulatory guidelines and requirements related to pharmacology and toxicology studies, particularly in the context of radiopharmaceuticals
  • Excellent analytical, problem-solving, and decision-making skills
  • Effective communication skills
  • Demonstrated ability to work collaboratively in a cross-functional environment
Responsibilities
  • Provide strategic direction and oversight for pharmacology and toxicology activities related to radiopharmaceutical development
  • Design, plan, and oversee preclinical pharmacology and toxicology studies to support regulatory submissions and product development
  • Lead, mentor, and develop a team of scientists and researchers focused on pharmacology and toxicology
  • Ensure all pharmacology and toxicology studies adhere to regulatory guidelines
  • Collaborate cross-functionally with other departments
  • Analyze and interpret pharmacological and toxicological data
  • Conduct thorough risk assessments to identify potential safety concerns
  • Stay abreast of the latest developments in pharmacology, toxicology, and radiopharmaceutical research
  • Manage the departmental budget effectively
  • Effectively communicate pharmacology and toxicology findings

Telix Pharmaceuticals develops and commercializes diagnostic and therapeutic radiopharmaceuticals for oncology and rare diseases, utilizing targeted radiation for personalized therapy and disease imaging. The company's pipeline includes products for prostate, kidney, brain, and hematologic cancers, supported by global regulatory approvals and a secure supply chain.

Company Stage

Grant

Total Funding

$63.5M

Headquarters

North Melbourne, Australia

Founded

2015

Growth & Insights
Headcount

6 month growth

19%

1 year growth

48%

2 year growth

135%